10% Off
10% Off
marketed by RUSAN
• 1PC
₹420.30
M.R.P.: ₹467
10% Off
Inclusive of all taxes
rupatch-tdp transdermal patch is used to treat moderate to severe pain. it works by blocking the chemical messengers in our bodies that are responsible for the sensation of pain. it helps to prevent withdrawal symptoms that can occur by withdrawal from other opioids. your doctor will explain how to use and follow the directions carefully for maximum benefit. the dose and duration will depend on
pregnancy breastfeeding kidney disease liver disease.
babies: it is not applicable.
lactation mother: consult your doctor because studies have shown evidence of risk to the baby.
pregnancy: consult your doctor because animal and human studies have shown harmful effects on the developing baby.
driving: no interactions found.
alcohol: no interactions found.
kidney: use this medication with caution in patients with kidney disease.
dose adjustment must be necessary.
liver: use this medication with caution in patients with liver disease.
dose adjustment must be necessary.
.
nausea constipation headache dizziness drowsiness.
it works by blocking the chemical messengers in our bodies that are responsible for the sensation of pain. .
if you miss a dose, take it as soon as possible.
if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily.
don't double the dose to catch up with the missed dose..
• rupatch-tdp transdermal patch must use as recommended by your doctor.
• you must change the patch every seven days and apply the new patch on the new site.
• do not expose the patch to any heat source.
• avoid alcohol or other drugs that can cause drowsiness.
• advise the patient to report symptoms of constipation.
• stop using this medicine and tell your doctor if you have trouble breathing.
• do not stop using this transdermal patch without informing your doctor first, as this may worsen symptoms.
.
• rupatch-tdp + lefamulin: concurrent use leads to an increase in rupatch-tdp levels by decreasing lefamulin.
• rupatch-tdp + abametapir: concurrent use leads to an increase in rupatch-tdp levels by decreasing abametapir.
• rupatch-tdp + alprazolam: concurrent use leads to an increase the sedation.
• rupatch-tdp + melatonin: concurrent use leads to an increase the sedation.
.
100% Authentic
Easy Return